« AMD Plans $500 mn In SemIndia SEZ (Fab City Project) | Home | HC To Huda: Maintain Status Quo On Kokapet »
Suven Life Sciences To Build New Discovery Site At Nandigama Village On The Outskirts Of Hyderabad
Posted by Pradeep Sadanapalli | August 30, 2006 | 385 views
(No Ratings Yet)
Loading ...Suven, Eli Lilly Ink Deal
HYDERABAD: Global drug major Eli Lilly has chosen city-based drug discovery company, Suven Life Sciences, to conduct pre-clinical research for a nervous system disorders (CNS) drug, with the goal of identifying potent, oral compounds that selectively modulate the specified G-Protein coupled receptor for the target CNS disease.Eli Lilly will make upfront investments on drug research by Suven, with the express objective of identifying three different compounds within the next 18 months. About 35 scientists will work on the project, Venkat Jasti, vice-chairman and CEO, Suven, told DNA Money.
Suven will receive payments from Lilly and potentially downstream payments if the identified candidates are selected for further pre-clinical research and development.
“If and when the product becomes a success, Suven will receive downstream royalties five to six years from now,” Jasti said, adding this was the first true research collaboration where a global major has trusted the capabilities of an Indian company.
The company will be also be paid a success fees on completion of the studies, along with bonuses for exceeding targets on various parameters.
Suven, which currently has 125 scientists working on drug discovery, is investing Rs 50 crore to build a new discovery site with a capacity for 400 scientists. The new facility will come up at Nandigama village on the outskirts of Hyderabad.
Meanwhile, it expects to file an investigation new drug application (INDA) in the US and Europe early next year for its promising lead compound 5-HT-6, which has completed pre-clinical trials.
Suven, which focuses on drugs to treat Alzheimer’s disease, schizophrenia, depression and Parkinson’s disease, employs 190 people in research and development.
About Eli Lilly & Co
In May 1876, Col. Eli Lilly, a U.S. Civil War veteran, founded the company that bears his name. Eli Lilly and Company quickly became one of the first companies to initiate a bona fide pharmaceutical program, hiring a young chemist to function as a full-time scientist, using and improving upon the newest techniques for quality evaluation.Eli Lilly and Company now enters its 130th year of business, with Headquarters at Indianapolis, Indiana, USA. Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that help people live longer, healthier and more active lives.
Lilly products treat depression, schizophrenia, attention-deficit hyperactivity disorder, diabetes, osteoporosis and many other conditions.
To name a few…
The most significant breakthrough in diabetes care since the 1920s was marked by Lilly’s 1982 introduction of Humulin insulin identical to that produced by the human body. Humulin is the world’s first human-health-care product created using recombinant DNA technology. Lilly later applied this technology to the introduction of Humatrope, a new therapy for growth hormone deficiency in children.
Lilly’s antidepressant Prozac®, the first selective serotonin reuptake inhibitor introduced into the United States to treat depression, is included on Fortune magazine’s “Products of the Century” list that recognizes innovative products from several categories. Prozac was introduced to the United States market in 1988 and has been used by more than 35 million people from 1988 to 2000.
About Suven Life Sciences Ltd
Suven Life Sciences provides world-class Drug Discovery and Development Support Services (DDDSS) and Contract Research and Manufacturing Services (CRAMS) to the Global Life Sciences industry through it’s India centric delivery model.
Suven has provided 18 Global Life Science majors over the past decade. It’s infrastructure includes two cGMP complaint manufacturing facilities and a pilot plant with state-of-the-art R&D center.
It is located in the city of Hyderabad, whic is known the world over as the Pharma Capital Of India. It’s manufacturing facilities are located at Suryapet, API’s near Sangareddy and R&D and pilot plant at Jeedimetla in the outskirts of Hyderabad.
Sources:
Daily News & Analysis - DNA Money
Eli Lilly
Suvens Life Sciences
Topics: Business News |
One Response to “Suven Life Sciences To Build New Discovery Site At Nandigama Village On The Outskirts Of Hyderabad”
Comments
You must be logged in to post a comment.
November 1st, 2006 at 2:05 am
Eli Lilly 10% profit rise is nearly all from Psyche drugs including zyprexa.
How have they schemed to squeeze more money from their zyprexa cash cow when pill production has actually gone down?
ANS-Eli Lilly profiteers have jacked up the price of zyprexa to the federal govt,from the Medicare D payouts.
Eli Lilly is a big drug company that puts profits over patients.
They covered up findings that their Zyprexa has a TEN times greater risk of causing type 2 diabetes
Only 9% of Americans trust big pharma,right around the same rating as tobacco companies.
Daniel Haszard Eli Lilly zyprexa drug caused my diabetes www.zyprexa-victims.com